Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Unum Therapeutics
3128
Unum Therapeutics
Technology
Biotechnology
Unum Therapeutics is a cellular therapeutics company ushering in a new wave in cancer immunotherapy.
Suggest edits
Founded
2014
Raised
$161.2M
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Xconomy
Money Mover
Biogen
HubSpot
Formlabs
General Catalyst
Akamai
Companies in the same industry
FoRx Therapeutics
Alume Biosciences
Creoptix
Genor Biopharma
Zelluna Immunotherapy
KetoSwiss
Olema Pharmaceuticals
GentiBio
Sequenta
Northwest Biotherapeutics
Alexa global traffic share
Twitter followers
Overview
Funding
4
Add info
Add round
29 Mar
2018
$69,200,000
IPO
VC-backed Unum Therapeutics rolls out IPO
PE HUB
15 Mar
2017
$15,000,000
Debt financing
Square 1 Bank
Unum Therapeutics Receives $15M Credit Facility from Square 1 Bank
FinSMEs
11 Jun
2015
$65,000,000
Venture capital (Series B)
Atlas Venture
,
Wellington Management
,
New Leaf Venture Partners
,
+9
21 Oct
2014
$12,000,000
Venture capital (Series A)
Atlas Venture
,
Fidelity Biosciences
,
Sanofi-Genzyme BioVentures
